Dr. Deeba Husain, MD
Ophthalmology (Ophthalmology Physician)
- Medicare participating
At a glance
- Years since graduation
- 40
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 833
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Ophthalmology Physician primary
MA license 203366
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Brigham and Women's Hospital Boston, MA
- Massachusetts General Hospital Boston, MA
- Massachusetts Eye and Ear Infirmary - Boston, MA
Medical groups
- Massachusetts Eye and Ear Associates, Inc (433 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 833
- Services billed
- 3,988
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Imaging of retina | 1,846 | 774 |
| Injection of drug into eye | 1,000 | 223 |
| Established patient office or other outpatient visit, 30-39 minutes | 950 | 658 |
| Established patient office or other outpatient visit, 40-54 minutes | 52 | 50 |
| New patient office or other outpatient visit, 45-59 minutes | 37 | 37 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisolone Acetate Other prescribers in Boston, MA | 50 |
| Ketorolac Tromethamine Other prescribers in Boston, MA | 18 |
| Dexamethasone Sodium Phosphate | 13 |
| Bromfenac Sodium | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $24.38 in total to this clinician.
| Inspire Medical Systems, Inc. | $24.38 |
|---|
| Food and Beverage | $24.38 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $22,185 in research payments for these studies, mostly to the institutions running them.
- A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Regeneron Pharmaceuticals, Inc. · Recruiting · NCT06541704
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.